In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

STEEER-AF Project Study

Developing, deploying and evaluating education evidence-based, needs-driven educational program in Atrial Fibrillation

Stroke prevention and rhythm control Therapy: Evaluation of an Educational Programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation. (STEEER-AF) Identifier: NCT04396418

STEER-AF-logo.pngAtrial Fibrillation (AF) is the most common sustained cardiac arrhythmias, with one in four middle-aged adults in developed countries expected to develop AF. By 2030, 14-17 million AF patients are anticipated in the European Union, with 120,000 – 215,000 newly diagnosed patients per year.

In 2014 the ESC performed a need assessment to understand the educational needs of cardiologists, neurologists & GPs/FPs in 6 countries in the following area:

  1. Current treatment & management of AF,
  2. Utilisation of optimal stroke prevention strategies with AF patients,
  3. Other potential issues & barriers in the management of AF.

This study identified that gaps in knowledge and skills of physicians is a major factor in poor adherence to guidelines. The two domains of AF therapy that most determine patient outcomes, namely stroke prevention and appropriate use of rhythm control, were also the two areas most in need of improvement.

This need assessment is now supporting the development of evidence-based educational interventions to be deployed in Germany, France, Italy, Spain, UK and Poland.

A quantitative study using Cluster Randomised trial in patients with Atrial Fibrillation will be used to assess outcome.

The start of STEEER-AF was delayed due to the current coronavirus pandemic; we aim to commence this trial when it is safe to do so and according to national lockdown policies.

Target Countries

  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Poland


STEEER-AF: a cluster-randomized education trial from the ESC: The STEEER-AF trial is designed by the European Society of Cardiology (ESC) to see if better education for healthcare professionals can improve how patients are treated and how AF is managed